Charles Schwab Investment Management Inc Viking Therapeutics, Inc. Transaction History
Charles Schwab Investment Management Inc
- $515 Billion
- Q3 2024
A detailed history of Charles Schwab Investment Management Inc transactions in Viking Therapeutics, Inc. stock. As of the latest transaction made, Charles Schwab Investment Management Inc holds 715,597 shares of VKTX stock, worth $37.6 Million. This represents 0.01% of its overall portfolio holdings.
Number of Shares
715,597
Previous 671,475
6.57%
Holding current value
$37.6 Million
Previous $35.6 Million
27.28%
% of portfolio
0.01%
Previous 0.01%
Shares
25 transactions
Others Institutions Holding VKTX
# of Institutions
473Shares Held
66.2MCall Options Held
5.72MPut Options Held
3.39M-
Vanguard Group Inc Valley Forge, PA10.2MShares$535 Million0.01% of portfolio
-
Black Rock Inc. New York, NY6.03MShares$317 Million0.01% of portfolio
-
State Street Corp Boston, MA4.67MShares$246 Million0.01% of portfolio
-
Jpmorgan Chase & CO New York, NY2.12MShares$111 Million0.01% of portfolio
-
Morgan Stanley New York, NY1.87MShares$98.6 Million0.01% of portfolio
About Viking Therapeutics, Inc.
- Ticker VKTX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 76,688,496
- Market Cap $4.03B
- Description
- Viking Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the development of novel therapies for metabolic and endocrine disorders. The company's lead drug candidate is VK2809, an orally available tissue and receptor-subtype selective agonist of the thyroid hormone receptor beta (TRß), which is in Phase IIb clinical trial...